[-] Show simple item record

dc.contributor.authorLo, Vincenteng
dc.contributor.authorNoviasky, Johneng
dc.contributor.authorNashelsky, Joaneng
dc.date.issued2006-06eng
dc.description.abstractThere is no evidence that anticoagulation with warfarin, initiated after a non- cardioembolic ischemic stroke, significantly reduces stroke recurrence. Furthermore, anticoagulation significantly increases the risk of fatal and nonfatal hemorrhagic stroke and extracranial hemorrhage in these patients. However, warfarin clearly is indicated for patients who have embolic strokes caused by underlying conditions such as atrial fibrillation or myxoma. (Strength of recommendation: A)eng
dc.identifier.citationAmerican Family Physician, 73(11) 2006.eng
dc.identifier.urihttp://hdl.handle.net/10355/3969eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2006 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectintracranial hemorrhageeng
dc.subjectcardioembolic strokeeng
dc.subjectantiplatelet agentseng
dc.subject.lcshWarfarineng
dc.subject.lcshCardiovascular system -- Diseaseseng
dc.subject.lcshIntracranial aneurysmseng
dc.subject.lcshSubarachnoid hemorrhageeng
dc.subject.lcshCerebral ischemiaeng
dc.subject.lcshAnticoagulantseng
dc.subject.lcshAtrial fibrillationeng
dc.titleWarfarin for Prevention of Ischemic Stroke Recurrence?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record